Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Longeveron Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- 0 vs. Q1 2022
- Shares held
- 378.2K
- −316.6K (−45.6%) vs. Q1 2022
- Total value
- $2.24M
- −$7.35M (−76.6%) vs. Q1 2022
- New holders
- 6
- 4 more added
- Sold out
- 6
- 2 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LGVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $3.35M |
| Q1 2026 | 31 | $2.37M |
| Q4 2025 | 30 | $520.6K |
| Q3 2025 | 29 | $783.1K |
| Q2 2025 | 25 | $868.1K |
| Q1 2025 | 21 | $790.6K |
| Q4 2024 | 24 | $844.4K |
| Q3 2024 | 19 | $512.3K |
| Q2 2024 | 21 | $534.1K |
| Q1 2024 | 12 | $161.7K |
| Q4 2023 | 22 | $3.42M |
| Q3 2023 | 19 | $1.37M |
| Q2 2023 | 21 | $2.71M |
| Q1 2023 | 16 | $1.13M |
| Q4 2022 | 17 | $1.45M |
| Q3 2022 | 18 | $1.64M |
| Q2 2022 | 14 | $2.24M |
| Q1 2022 | 14 | $9.59M |
| Q4 2021 | 19 | $5.55M |
| Q3 2021 | 13 | $1.07M |
| Q2 2021 | 12 | $2.96M |
| Q1 2021 | 10 | $561.0K |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Longeveron Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 173,667 | $1.03M | 0.00% | +57,802+49.9% | Added |
| BlackRock Inc. | 109,999 | $652.0K | 0.00% | +27,010+32.5% | Added |
| Geode Capital Management, LLC | 35,718 | $211.0K | 0.00% | +1,783+5.3% | Added |
| State Street Corp | 14,800 | $88.0K | 0.00% | +14,800 | New |
| TownSquare Capital, LLC | 14,450 | $86.0K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 14,100 | $83.0K | 0.00% | −174,310−92.5% | Reduced |
| Northern Trust Corp | 10,623 | $63.0K | 0.00% | +10,623 | New |
| Advisor Group Holdings, Inc. | 2,000 | $12.0K | 0.00% | +2,000 | New |
| Morgan Stanley | 1,300 | $8.00K | 0.00% | −50−3.7% | Reduced |
| Tower Research Capital LLC (TRC) | 631 | $4.00K | 0.00% | +631 | New |
| UBS Group AG | 510 | $3.00K | 0.00% | +510 | New |
| The PNC Financial Services Group, Inc. | 220 | $1.00K | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 105 | $1.00K | 0.00% | +105 | New |
| Wells Fargo & Company | 32 | $0 | 0.00% | +4+14.3% | Added |
| Sassicaia Capital Advisers LLC | 0 | $0 | 0.00% | −102,004−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −72,779−100.0% | Sold out |
| Gamco Investors, Inc. Et Al | 0 | $0 | 0.00% | −32,500−100.0% | Sold out |
| Anson Funds Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −19,655−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,617−100.0% | Sold out |